Nkarta is working on engineered NK cell therapies for autoimmune diseases and cancer. Click here to find out why I maintain a ...

Pfizer (PFE) stock fell even as the company beat forecasts with its Q3 results and increased its full-year outlook.Find out ...

The company has also laid off 39% of its staff as it discontinued the development of SPR720 for non-tuberculous mycobacterial ...

The company has axed 80% of its staff and is considering a wind-down after the out-licencing deal of its lead antifungal was ...

The deal will give Lyell a dual-targeting CAR-T candidate for blood cancers. Relatedly, Lyell will also end development of ...

Intellia Therapeutics' Phase 2 data shows NTLA-2002, a CRISPR gene therapy, reduced hereditary angioedema attack rates by up ...

MeiraGTx Holdings’ MGTX clinical bridging study of its gene therapy candidate, AAV-GAD, for treating Parkinson’s disease (PD) ...

Merck and Moderna initiate Phase 3 trial of mRNA-4157 (V940) with Keytruda as adjuvant for NSCLC patients, marking progress ...

On Wednesday, Ocuphire Pharma, Inc. (NASDAQ:OCUP) announced the all-stock acquisition of Opus Genetics, Inc., a ...

Dear Abby gives advice to a woman who wants her sister to see a professional therapist instead of solely confiding in her.

Goran – stock.adobe.com The psychotherapist suggests revealing thoughts such as “I felt uncomfortable when you told your mother about our private business,” helps you navigate the issue head ...

The FDA approved Astellas' gastric cancer therapy. CVS Health CEO Karen Lynch steps down amid shareholder pressure, with ...